SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRK is drawing attention after a sharp rally tied to StarkWares quantum-security narrative and talk of Starknet potentially becoming an independent, quantum-resistant Layer 1. Traders are bullish on the breakout and Starknets privacy and Bitcoin DeFi plans, while others warn the move could be a short-lived pump and point to token unlocks and profit-taking as risks.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa has put FDA acceptance and review timing at the center of discussion. Traders are split: some see the filing as progress toward approval, while others remain wary of regulatory and commercial risks, competition, and managements plan to launch independently.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastems planned VS-7375 clinical update across pancreatic, lung and colorectal cancers is the main focus, with traders comparing encouraging GenFleet results and recent concerns about competing KRAS drugs against the need for Verastem to demonstrate efficacy, durability and tolerability in its own data. Sentiment is hopeful but cautious, and RAMP 201 ovarian-cancer analyses are a secondary topic amid frustration that positive pipeline developments have not lifted the share price more.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobes quarterly results beat expectations, but shares faced pressure as investors focused on a softer near-term revenue outlook and slowing recurring-revenue growth. Traders remain divided over whether Adobe can turn rising AI adoption into durable paid growth, with AI disruption fears and the CEO transition adding uncertainty.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

PENGU is being discussed amid crypto and meme-coin weakness, with traders pointing to Bitcoins decline and uncertainty around Abstract as pressure on the token. Views are split: some see the pullback as a buying opportunity and argue that winding down Abstract could refocus effort on Pudgy Penguins, while others expect further losses.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

FDA review documents highlighting weaker daraxonrasib responses in the KRAS G12D subgroup have stirred concern about RASONQUEs efficacy and opened debate about competition from Verastems VS-7375. Traders are split between viewing the data as a threat and calling the selloff an overreaction, arguing that broader survival outcomes matter more than response rates alone.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is drawing attention around a choppy consolidation, with traders repeatedly discussing technical levels, liquidity sweeps, and whether a recent bounce can extend. Views are mixed: some see further upside, while others describe the coin as weak and warn of bull traps or another dip.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarins steep slide toward 52-week lows is drawing complaints about management and weak investor interest, despite bullish arguments that the companys cash balance and international growth are undervalued. Traders are also debating the pending LR-EtEPA patent and upcoming EMT-2 results as potential catalysts, while buyout talk remains speculative.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadots steep decline and repeated lows are driving the discussion, with many traders criticizing its prolonged underperformance and questioning demand while others view the weakness as a buying opportunity and continue accumulating or staking DOT. Reports of an exploit involving a wrapped DOT token have added concern, though some traders stress that it did not involve native DOT.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

TAOs recent price rise is drawing attention, with traders discussing a bullish chart setup, adding to positions, and citing Bittensors decentralized-AI network and limited token supply as reasons for their optimism. The conversation is largely bullish, though some traders remain cautious about whether the move can hold.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Reports that Starbucks explored a potential Chipotle takeover are driving the discussion, with traders weighing the CEO connection against the deals scale and Starbucks need to focus on its turnaround. Many view the acquisition as unlikely or a distraction, while uncertainty around the rumor is being linked to pressure on SBUX shares.

Massive News for Chipotle and Starbucks Investors

A potential acquisition could add shareholder value in several key ways...

Chipotle and Starbucks are reportedly coming together, but do their brand ethos fit?

Chipotle and Starbucks are reportedly coming together, but do their brand ethos fit...

Squawk Pod: SpaceX aims for telecom, Starbucks eyes Chipotle - 10/09/26  Audio Only

Squawk Pod: SpaceX aims for telecom, Starbucks eyes Chipotle - 10/09/26 | Audio Only...

Bernstein's Danilo Gargiulo: We do not think potential Starbucks takeover of Chipotle will happen

Bernstein's Danilo Gargiulo: We do not think potential Starbucks takeover of Chipotle will happen...

DA Davidson Sees Limited Odds Of Starbucks-Chipotle Deal Being Completed Despite Some Strategic Rationale 

Equity

According to The Fly, DA Davidson sees just 20% odds of the reported deal being completed, while analysts remain divided on the deal’s strategic benefits and potential risks.

Would you order a burrito bowl at Starbucks?

Would you order a burrito bowl at Starbucks...

Starbucks Explores CMG Deal: Smart Move or Costly Gamble?

SBUX has reportedly explored a Chipotle takeover, but potential growth opportunities must be weighed against financing costs, integration risks and its ongoing turnaround.

What's Going On With Starbucks Stock Friday?

Starbucks explores a potential takeover of Chipotle as investors weigh deal risks against CEO Brian Niccol's ongoing turnaround plan.read more...

Investors Heavily Search Starbucks Corporation (SBUX): Here is What You Need to Know

Starbucks (SBUX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Wall Street Warns Starbucks' Reported Chipotle Takeover Could Backfire  Brian Niccol Could Be Taking a 'Risky' Gamble Mid-Turnaround

Analysts question Starbucks' reported interest in acquiring Chipotle, warning the mega-deal could complicate its ongoing turnaround.read more...

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Bullish Sentiment

Track SBUX stock price, charts, news and real-time market activity on Stocktwits. Join the SBUX message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Starbucks Corp stock.

SBUX Stock Price Today - Starbucks Corp News, Charts, Retail Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$90.75
Prev Close	$93.21
Open	$93.00
Dividend Yield	2.93%
50-Day Moving Average	$101.26
Beta	0.88
Avg. Volume	6.83M
PE Ratio	52.33

52-Week High	$110.51
52-Week Low	$77.99
Market Capitalization	$103.45B
EPS (Annual)	$1.63
Price to Book	-13.48
Revenue Per Employee	$97,537.79

Feed

News

Sentiment

Earnings

NewFutures

Fundamentals

Info

SBUX Fundamentals